[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342634-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342634-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","lymphatic-endothelial-cell-mediated-accumulation-of-cd177treg-cells-suppresses-antitumor-immunity-in-human-esophageal-squamous-cell-carcinoma","Lymphatic endothelial cell-mediated accumulation of CD177+Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma","","Regulatory T (Treg) cells shape an immunosuppressive tumor microenvironment that drives progression and therapy resistance, yet Treg heterogeneity in esophageal squamous cell carcinoma (ESCC) remains insufficiently defined. CD177 was identified as a tumor-infiltrating Treg marker with distinct relationships to PD-1, IL35, and IL10. CD177+ Treg cells show greater clonal expansion, correlate with poor survival and worse anti–PD-1 immunotherapy plus chemotherapy responses. Lymphatic endothelial cells promote CD177+ Treg accumulation and decline after treatment, suggesting prognostic and therapeutic value in ESCC.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/lymphatic-endothelial-cell-mediated-accumulation-of-cd177treg-cells-suppresses-antitumor-immunity-in-human-esophageal-squamous-cell-carcinoma/342634/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/lymphatic-endothelial-cell-mediated-accumulation-of-cd177treg-cells-suppresses-antitumor-immunity-in-human-esophageal-squamous-cell-carcinoma/342634.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is CD177’s role in Treg cells in ESCC?","Question",{"text":63,"@type":64},"CD177 was identified as a tumor-infiltrating Treg cell marker in ESCC and defines a specific Treg subset associated with immunosuppression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do CD177+ and PD-1+ Treg cells differ functionally?",{"text":68,"@type":64},"CD177+ Treg cells express high IL35 linked to CD8+ T-cell exhaustion, while PD-1+ Treg cells express high IL10.",{"name":70,"@type":61,"acceptedAnswer":71},"Which factor links lymphatic endothelial cells to CD177+ Treg accumulation and treatment effects?",{"text":72,"@type":64},"Lymphatic endothelial cells are associated with CD177+ Treg accumulation in ESCC tumors, and this accumulation decreases after anti–PD-1 immunotherapy plus chemotherapy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342634,1790479513,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","ONCOIMMUNOLOGY  \n2024, VOL. 13, NO. 1, 2327692 [https://doi.org/10.1080/2162402X.2024.2327692](https://doi.org/10.1080/2162402X.2024.2327692)  \nORIGINAL RESEARCH     \nLymphatic endothelial cell-mediated accumulation of CD177+Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma  \nMin Maa,b*, Liang Li c*, Shu-Han Yangb, Chuan Huanga,b, Weitao Zhuangd, Shujie Huangd, Xin Xiad, Yong Tangd, Zijun Lie, Zhi-Bin Zhaoc, Qingyun Chenc, Guibin Qiaod, and Zhe-Xiong Lian a,b  \naChronic Disease Laboratory, School of Medicine South China University of Technology, Guangzhou, China; bGuangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China; cMedical Research Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China; dDepartment of Thoracic Surgery, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China; eGuangdong Provincial Institute of Geriatrics, Concord Medical Center, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China  \nABSTRACT  \nRegulatory T (Treg) cells are critical in shaping an immunosuppressive microenvironment to favor tumor progression and resistance to therapies. However, the heterogeneity and function of Treg cells in esophageal squamous cell carcinoma (ESCC) remain underexplored. We identified CD177 as a tumor-infiltrating Treg cell marker in ESCC. Interestingly, expression levels of CD177 and PD-1 were mutually exclusive in tumor Treg cells. CD177+ Treg cells expressed high levels of IL35, in association with CD8+ T cell exhaustion, whereas PD-1+ Treg cells expressed high levels of IL10. Pan-cancer analysis revealed that CD177+ Treg cells display increased clonal expansion compared to PD-1+ and double-negative (DN) Treg cells, and CD177+ and PD-1+ Treg cells develop from the same DN Treg cell origin. Importantly, we found CD177+ Treg cell infiltration to be associated with poor overall survival and poor response to anti-PD-1 immunotherapy plus chemotherapy in ESCC patients. Finally, we found that lymphatic endothelial cells are associated with CD177+ Treg cell accumulation in ESCC tumors, which are also decreased after anti-PD-1 immunotherapy plus chemotherapy. Our work identifies CD177+ Treg cell as a tumor-specific Treg cell subset and highlights their potential value as a prognostic marker of survival and response to immunotherapy and a therapeutic target in ESCC.  \nARTICLE HISTORY  \nReceived 6 October 2023 Revised 30 January 2024 Accepted 4 March 2024  \nKEYWORDS  \nAnti-PD-1 immunotherapy; esophageal squamous cell carcinoma; regulatory T cell; tumor microenvironment; CD177; Lymphatic endothelial cell  \nIntroduction  \nESCC is a common form of esophageal cancer, accounting for more than 90% of cases worldwide. 1 ESCC is a highly aggressive cancer that is often diagnosed at advanced stages. Despite advances in treatment, the overall survival rate of ESCC patients remains low, highlighting the need for a better understanding of the disease. The immunosuppressive microenvironment is important in promoting tumor growth and metastasis in ESCC.2 Regulatory T (Treg) cells play a critical role in immune suppression in the tumor microenvironment;  \nhowever, their function in ESCC is poorly understood.  \nTreg cells assist in tumor immune evasion mainly by secreting suppressive cytokines and expressing inhibitory receptors,3 which inhibit antitumor T-cell and NK cell activation. Similar to tumor antigen-specific cytotoxic T cells, which are crucial in antitumor immunity, only a subset of Treg cells is critical in suppressing antitumor immunity during tumor progression.4 An increasing number of studies have reported unique subsetsofTreg cells that contribute to tumor growth. CCR8+ Treg cells  \nsuppress the antitumor i","cbCaio7om1ZB1zPv","https://ap.wps.com/l/cbCaio7om1ZB1zPv","pdf",6444083,16,"English","# Introduction\n# Results\n## CD177 as a tumor-infiltrating Treg marker\n## Distinct phenotypes associated with PD-1, IL35, and IL10\n## Prognostic value and therapy response in ESCC\n## Role of lymphatic endothelial cells","[{\"question\":\"What is CD177’s role in Treg cells in ESCC?\",\"answer\":\"CD177 was identified as a tumor-infiltrating Treg cell marker in ESCC and defines a specific Treg subset associated with immunosuppression.\"},{\"question\":\"How do CD177+ and PD-1+ Treg cells differ functionally?\",\"answer\":\"CD177+ Treg cells express high IL35 linked to CD8+ T-cell exhaustion, while PD-1+ Treg cells express high IL10.\"},{\"question\":\"Which factor links lymphatic endothelial cells to CD177+ Treg accumulation and treatment effects?\",\"answer\":\"Lymphatic endothelial cells are associated with CD177+ Treg accumulation in ESCC tumors, and this accumulation decreases after anti–PD-1 immunotherapy plus chemotherapy.\"}]","Lymphatic endothelial cell-mediated accumulation of CD177+Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma | PDF",1790047489,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a02106f718b9b82077f6af2f6e804560.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20e08dc356b78579f4f711b49af67dc4.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2abd9c238cfb4dea02e4002119badae.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dfae0b5e2f8675bdfa4c35553be3f9da.webp",980,1306]